Lovastatin Tablet
Product Images NDC 71335-0882

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lovastatin (NDC 71335-0882). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lovastatin (65abb8c3 847f 4fb3 B8de 21888c01210b 01)

Chemical structure of lovastatin, showing its molecular arrangement with multiple rings, hydroxyl, ketone, and ester functional groups.*

FDA Label Image

Figure 1 (65abb8c3 847f 4fb3 B8de 21888c01210b 02)

A line graph titled 'Acute Major Coronary Events (Primary Endpoint)' showing the proportion of participants without event over years of follow-up. Two lines are plotted, one for Lovastatin and one for Placebo, illustrating a 37% risk reduction with Lovastatin (p<0.0001) compared to Placebo over approximately 6 years.*

FDA Label Image

Label (Lbl713350882)

Label for Lovastatin Tablets, USP 40 mg, repackaged by Bryant Ranch Prepack, Inc. It shows a package containing 30 tablets labeled 'Rx only.' Manufactured by Lupin Limited, the label includes storage instructions and two barcodes, including one with NDC 71335-0882-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.